- Home
- FTHM vs FGEN Comparison
FTHM vs FGEN Comparison
Compare FTHM & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTHM
- FGEN
- Stock Information
- Founded
- FTHM 2010
- FGEN 1993
- Country
- FTHM United States
- FGEN United States
- Employees
- FTHM N/A
- FGEN N/A
- Industry
- FTHM Real Estate
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- FTHM Finance
- FGEN Health Care
- Exchange
- FTHM Nasdaq
- FGEN Nasdaq
- Market Cap
- FTHM 33.6M
- FGEN 33.5M
- IPO Year
- FTHM 2020
- FGEN 2014
- Fundamental
- Price
- FTHM $1.27
- FGEN $7.26
- Analyst Decision
- FTHM Buy
- FGEN Strong Buy
- Analyst Count
- FTHM 1
- FGEN 1
- Target Price
- FTHM $2.50
- FGEN $250.00
- AVG Volume (30 Days)
- FTHM 87.1K
- FGEN 74.1K
- Earning Date
- FTHM 08-11-2025
- FGEN 08-05-2025
- Dividend Yield
- FTHM N/A
- FGEN N/A
- EPS Growth
- FTHM N/A
- FGEN N/A
- EPS
- FTHM N/A
- FGEN N/A
- Revenue
- FTHM $357,816,000.00
- FGEN $6,996,000.00
- Revenue This Year
- FTHM $32.40
- FGEN N/A
- Revenue Next Year
- FTHM $18.04
- FGEN N/A
- P/E Ratio
- FTHM N/A
- FGEN N/A
- Revenue Growth
- FTHM 5.80
- FGEN N/A
- 52 Week Low
- FTHM $0.65
- FGEN $4.50
- 52 Week High
- FTHM $3.37
- FGEN $38.25
- Technical
- Relative Strength Index (RSI)
- FTHM 53.30
- FGEN 60.54
- Support Level
- FTHM $1.27
- FGEN $5.37
- Resistance Level
- FTHM $1.39
- FGEN $5.73
- Average True Range (ATR)
- FTHM 0.10
- FGEN 0.49
- MACD
- FTHM 0.01
- FGEN 0.27
- Stochastic Oscillator
- FTHM 61.54
- FGEN 83.80
About FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.